The FDA has warned that ketamine and compounded ketamine products aren’t approved to deal with any psychiatric disorder. This implies that they haven’t been confirmed being safe or effective. In 2019, the FDA approved a nasal spray called esketamine (Spravato) that’s derived from ketamine for treatment-resistant depression, but only in https://eugenec036nvw1.wikijournalist.com/user